Looking in from above and up from below: new vistas in thoracic surgery.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 22885455)

Published in Innovations (Phila) on August 13, 2012

Authors

Frank C Detterbeck, Anthony W Kim, Marcin Zielinski

Articles citing this

Single-port thymectomy using a subxiphoid approach-surgical technique. Ann Cardiothorac Surg (2016) 0.75

Articles by these authors

Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71

Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol (2006) 5.09

Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 3.82

Clinical practice. Superior vena cava syndrome with malignant causes. N Engl J Med (2007) 3.39

Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 3.39

ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg (2007) 2.37

ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg (2006) 2.33

Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 2.16

Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer? J Thorac Oncol (2010) 2.00

Outcomes for lung transplantation for lung cancer in the United Network for Organ Sharing Registry. Ann Thorac Surg (2012) 1.99

Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol (2010) 1.94

Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results. J Clin Oncol (2013) 1.91

Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg (2014) 1.90

Counterpoint: are limited resections appropriate in non-small cell lung cancer? No: don't overdo it, and don't get confused. Chest (2012) 1.60

Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg (2011) 1.59

Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol (2004) 1.56

Helical computed tomography inaccuracy in the detection of pulmonary metastases: can it be improved? Ann Thorac Surg (2007) 1.54

"Back to the future": recruiting the best and brightest into cardiothoracic surgery. J Thorac Cardiovasc Surg (2010) 1.53

Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.50

Standard outcome measures for thymic malignancies. J Thorac Oncol (2010) 1.39

Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol (2004) 1.37

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer. J Thorac Oncol (2015) 1.34

The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database. Cancer (2007) 1.21

The impact of thymoma histotype on prognosis in a worldwide database. J Thorac Oncol (2015) 1.20

Stereotactic body radiotherapy for central lung tumors. J Thorac Oncol (2012) 1.18

Superior vena cava syndrome--a proposed classification system and algorithm for management. J Thorac Oncol (2008) 1.16

Standard terms, definitions, and policies for minimally invasive resection of thymoma. J Thorac Oncol (2011) 1.16

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 1.12

An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg (2011) 1.08

New TNM classification for non-small-cell lung cancer. Expert Rev Anticancer Ther (2009) 1.07

Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg (2008) 1.06

Lumping, splitting, and sorting. J Thorac Oncol (2007) 1.01

Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol (2009) 1.01

Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res (2010) 1.01

Trends in the outcomes for patients with limited stage small cell lung cancer: An analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer (2008) 0.99

Bilateral intrathoracic kidneys and adrenal glands associated with posterior congenital diaphragmatic hernias. Ann Thorac Surg (2008) 0.98

Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg (2013) 0.98

The effect of a lung cancer care coordination program on timeliness of care. Clin Lung Cancer (2013) 0.98

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol (2014) 0.98

Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg (2007) 0.97

Psoas muscle metastases in non-small cell lung cancer. J Thorac Dis (2012) 0.97

Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review. J Thorac Cardiovasc Surg (2011) 0.95

Multifocal right atrial myxoma and pulmonary embolism. Ann Thorac Surg (2003) 0.95

A systematic review of restaging after induction therapy for stage IIIa lung cancer: prediction of pathologic stage. J Thorac Oncol (2010) 0.95

Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J Thorac Oncol (2015) 0.94

Central pancreatectomy for the resection of benign or low malignant potential neoplasms. World J Surg (2003) 0.94

Accuracy of helical CT in the detection of pulmonary metastases: is intraoperative palpation still necessary? Ann Thorac Surg (2004) 0.94

Roux-en-Y duodenojejunostomy in the treatment of Bouveret syndrome. South Med J (2009) 0.92

Details and difficulties regarding the new lung cancer staging system. Chest (2010) 0.92

Central pancreatectomy for a pancreatic ganglioneuroma in a patient with previous neuroblastoma. Pancreatology (2002) 0.92

Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS). Support Care Cancer (2008) 0.90

Patients Selected for Definitive Concurrent Chemoradiation at High-volume Facilities Achieve Improved Survival in Stage III Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.90

Molecular classification of nonsmall cell lung cancer using a 4-protein quantitative assay. Cancer (2011) 0.90

Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol (2015) 0.90

Use of new treatment modalities for non-small cell lung cancer care in the Medicare population. Chest (2013) 0.89

A practical guide from the International Thymic Malignancy Interest Group (ITMIG) regarding the radiographic assessment of treatment response of thymic epithelial tumors using modified RECIST criteria. J Thorac Oncol (2014) 0.89

The fable of Babel and building a foundation for quality. J Thorac Oncol (2012) 0.89

In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation. J Biol Chem (2006) 0.89

Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer. Am Surg (2003) 0.87

Minimally invasive oesophagectomy more expensive than open despite shorter length of stay. Eur J Cardiothorac Surg (2013) 0.87

Right middle lobectomy for a primary pulmonary leiomyoma: a case report. Cases J (2009) 0.87

Establishment of a multi-analyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer. J Thorac Oncol (2009) 0.86

First case of heterochthonous subconjunctival dirofilariasis described in Poland. Am J Trop Med Hyg (2010) 0.86

Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. Eur J Cardiothorac Surg (2013) 0.85

Screening for lung cancer: moving into a new era. Ann Intern Med (2013) 0.85

Treatment of locally advanced non-small cell lung cancer. Clin Adv Hematol Oncol (2009) 0.85

Standard outcome measures for thymic malignancies. J Thorac Oncol (2011) 0.85

Enhancement of a multianalyte serum biomarker panel to identify lymph node metastases in non-small cell lung cancer with circulating autoantibody biomarkers. Int J Cancer (2010) 0.85

Beliefs among physicians in the diagnostic and therapeutic approach to non-small cell lung cancer. J Thorac Oncol (2007) 0.84

Fast cytological evaluation of lymphatic nodes obtained during transcervical extended mediastinal lymphadenectomy. Eur J Cardiothorac Surg (2013) 0.84

The feasibility of adjuvant carboplatin and docetaxel in patients with curatively resected non-small cell lung cancer. J Thorac Oncol (2008) 0.84

Rare pleural tumors. Clin Chest Med (2013) 0.83

The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy. Ann Thorac Surg (2009) 0.82

Enucleation of a giant esophageal gastrointestinal stromal tumor. Ann Thorac Surg (2009) 0.82

Age is a strong risk factor for atrial fibrillation after pulmonary lobectomy. Am J Surg (2010) 0.82

Correction of postpneumonectomy syndrome using a custom implant. BMJ Case Rep (2011) 0.81

Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation. Mod Pathol (2004) 0.81

An unusual case of Aspergillus fibrosing mediastinitis. Ann Thorac Surg (2009) 0.81

Pediatric thymomas: report of two cases and comprehensive review of the literature. Pediatr Surg Int (2013) 0.81

Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer. Ann Thorac Surg (2012) 0.81

A modern definition of mediastinal compartments. J Thorac Oncol (2014) 0.81

Of buffaloes, horseshoes, and having no connections. Ann Thorac Surg (2005) 0.81

Lobectomy versus limited resection in T1N0 lung cancer. Ann Thorac Surg (2013) 0.81

The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol (2014) 0.80

Current status of lung cancer screening. Semin Thorac Cardiovasc Surg (2012) 0.80

Assessment of real-time 3D visualization for cardiothoracic diagnostic evaluation and surgery planning. J Digit Imaging (2005) 0.80

Learning curve to lymph node resection in minimally invasive esophagectomy for cancer. Innovations (Phila) (2014) 0.80

Stage I Lung SBRT Clinical Practice Patterns. Am J Clin Oncol (2017) 0.80

Overview. J Thorac Oncol (2014) 0.79